Hepatocellular Carcinoma, An Issue of Surgical Oncology Clinics of North America

In this issue of <i>Surgical Oncology Clinics</i>, guest editors Drs. Adam Yopp and Maria B. Majella Doyle bring their considerable expertise to the topic of <b>Hepatocellular Carcinoma</b>. Top experts in the field explore promising recent advances in the treatment of all stages of hepatocellular carcinoma (HCC), neoadjuvant or downstaging therapy, the role of LI-RADS in hepatocellular carcinoma, surveillance of hepatocellular carcinoma, liver transplantation, and more.<ul><li>Contains <b>13 relevant, practice-oriented topics</b>, including the changing epidemiology of HCC within the US and worldwide; HCC surveillance: evidence-based tailored approach; surgical resection outside early stage HCC; minimally invasive techniques for HCC resection; overview of current HCC staging systems: is there an optimal system?; and more.</li><li>Provides in-depth <b>clinical reviews on hepatocellular carcinoma</b>, offering actionable insights for clinical practice.</li><li>Presents the <b>latest information on this timely, focused topic</b> under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.</li></ul>